| Database ID | Agent | Target | Cancer Type | Detail |
| DB00616 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00617 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00618 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00619 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00620 | sunitinib | FL cytokine receptor
Mast/stem cell growth factor receptor
Vascular endothelial growth factor receptor 2
Plateletderived growth factor receptor | Tumors of the nervous system | view |
| DB00621 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00622 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00623 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00624 | AMG102 | hepatocyte growth factor/scatter factor (HGF/SF) | Tumors of the nervous system | view |
| DB00625 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00626 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00627 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00628 | bevacizumab and erlotinib | NA | Tumors of the nervous system | view |
| DB00629 | bevacizumab | Vascular endothelial growth factor | Tumors of the nervous system | view |
| DB00630 | Cetuximab, bevacizumab | NA | Tumors of the nervous system | view |